Loading…
Elantas Beck India (ELANTAS)₹11,858−1.15%Specialty Chemicals
In the Jun 2026 quarter (standalone), Elantas Beck India reported sales of ₹283 Cr, up 34.7% from Jun 2025, and net profit of ₹71.02 Cr, up 82.0% year on year. For the year to Dec 2025, sales were ₹850 Cr and net profit ₹148 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 163 | 174 | 177 | 191 | 184 | 197 | 206 | 210 | 217 | 215 | 222 | 283 |
| Expenses | 126 | 138 | 139 | 153 | 150 | 162 | 166 | 170 | 169 | 170 | 179 | 202 |
| Operating Profit | 36.94 | 35.94 | 37.88 | 38.90 | 32.90 | 34.92 | 39.90 | 39.93 | 46.87 | 44.92 | 42.93 | 81.77 |
| OPM % | 22.9% | 19.9% | 20.9% | 19.9% | 18.0% | 18.0% | 20.0% | 19.0% | 21.9% | 21.0% | 20.0% | 29.0% |
| Other Income | 11.99 | 17.01 | 14.99 | 16.99 | 12.01 | 9.99 | 8.99 | 17.99 | 6.99 | 13.98 | 2.99 | 18.98 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.99 | 2.99 | 2.99 | 2.99 | 3.99 | 4.99 | 4.99 | 4.99 | 5.99 | 5.99 | 5.99 | 5.99 |
| Profit before tax | 47.02 | 49.03 | 49.08 | 52.01 | 42.03 | 40.02 | 44.05 | 53.02 | 49.05 | 53.07 | 40.02 | 95.13 |
| Tax % | 25.1% | 25.1% | 25.1% | 20.1% | 25.1% | 26.1% | 26.0% | 26.0% | 25.0% | 25.0% | 23.1% | 25.1% |
| Net Profit | 35.03 | 37.05 | 37.04 | 42.01 | 31.02 | 30.03 | 33.01 | 39.03 | 36.03 | 39.03 | 31.03 | 71.02 |
| EPS (Rs) | 43.86 | 46.54 | 46.44 | 52.71 | 39.09 | 37.43 | 41.35 | 49.44 | 45.64 | 49.59 | 39.14 | 89.19 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 345 | 366 | 383 | 409 | 394 | 383 | 522 | 646 | 681 | 750 | 850 | 938 |
| Expenses | 282 | 286 | 304 | 344 | 340 | 312 | 443 | 534 | 537 | 603 | 675 | 719 |
| Operating Profit | 61.82 | 78.82 | 77.81 | 64.85 | 53.86 | 69.80 | 77.85 | 110 | 143 | 144 | 172 | 216 |
| OPM % | 18.0% | 22.0% | 19.9% | 16.0% | 13.9% | 18.0% | 15.0% | 16.9% | 20.9% | 19.0% | 20.0% | 23.1% |
| Other Income | 5.99 | 7.99 | 8.99 | 30.99 | 17.99 | 21.99 | 24.99 | 31.96 | 53.01 | 54.96 | 47.94 | 42.94 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 |
| Depreciation | 5.99 | 4.99 | 5.99 | 6.99 | 6.99 | 11.98 | 11.98 | 11.97 | 11.98 | 14.96 | 20.97 | 23.96 |
| Profit before tax | 62.08 | 81.01 | 81.08 | 89.09 | 64.06 | 80.02 | 91.09 | 129 | 184 | 183 | 199 | 237 |
| Tax % | 32.1% | 33.0% | 32.0% | 26.0% | 22.1% | 23.1% | 27.1% | 24.1% | 25.1% | 24.1% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 13.95 | 0.00 | 0.00 | 6.97 | 7.97 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 42.04 | 54.01 | 55.01 | 66.09 | 50.04 | 62.06 | 67.05 | 98.13 | 137 | 140 | 148 | 177 |
| EPS (Rs) | 52.53 | 68.54 | 69.32 | 82.75 | 62.39 | 77.77 | 84.22 | 123.02 | 172.71 | 175.65 | 186.15 | 223.56 |
| Dividend payout % | 9.0% | 7.0% | 6.0% | 5.0% | 8.0% | 6.0% | 6.0% | 4.0% | 3.0% | 4.0% | 4.0% | — |
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.01 | 8.02 | 8.00 | 8.02 | 8.00 | 8.02 | 8.02 | 8.02 | 8.02 | 8.00 | 8.02 | 8.02 |
| Reserves | 128 | 164 | 214 | 270 | 331 | 376 | 433 | 496 | 591 | 723 | 858 | 999 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 57.27 | 64.31 | 70.34 | 70.34 | 76.37 | 72.35 | 95.45 | 115 | 120 | 150 | 149 | 159 |
| Total Liabilities | 192 | 236 | 291 | 348 | 415 | 456 | 536 | 618 | 717 | 881 | 1,015 | 1,165 |
| Fixed Assets | 44.91 | 44.91 | 35.94 | 39.94 | 69.86 | 110 | 103 | 97.82 | 97.84 | 98.77 | 223 | 239 |
| CWIP | 0.99 | 0.00 | 4.99 | 14.99 | 0.00 | 9.99 | 17.98 | 18.98 | 12.98 | 16.99 | 18.97 | 7.99 |
| Investments | 29.97 | 63.93 | 109 | 139 | 174 | 160 | 218 | 261 | 356 | 516 | 379 | 591 |
| Other Assets | 116 | 126 | 140 | 154 | 171 | 176 | 198 | 240 | 250 | 248 | 395 | 327 |
| Inventories | 52.01 | 50.97 | 55.99 | 45.02 | 51.03 | 50.02 | 52.99 | 84.06 | 79.99 | 73.01 | 95.01 | 97.02 |
| Trade receivables | 49.03 | 56.06 | 53.09 | 73.06 | 84.14 | 61.04 | 71.12 | 87.10 | 102 | 102 | 127 | 140 |
| Cash & equivalents | 7.01 | 12.01 | 17.02 | 22.01 | 10.01 | 24.03 | 27.03 | 18.02 | 42.06 | 57.02 | 153 | 69.07 |
| Total Assets | 192 | 236 | 291 | 348 | 415 | 456 | 536 | 618 | 717 | 881 | 1,015 | 1,165 |
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 30.97 | 45.98 | 55.94 | 50.92 | 32.97 | 47.96 | 78.87 | 28.97 | 82.96 | 133 | 62.98 | 127 |
| Cash from investing activity | 19.05 | −42.11 | −51.10 | −45.09 | −32.08 | −40.07 | −69.17 | −33.10 | −76.22 | −132 | 78.21 | −195 |
| Cash from financing activity | −51.09 | −4.01 | −5.01 | −5.01 | −4.01 | −5.01 | −4.01 | −4.01 | −5.01 | −5.01 | −5.01 | −6.01 |
| Net cash flow | −1.99 | 0.00 | 0.00 | 1.99 | −2.99 | 3.99 | 5.98 | −7.97 | 1.99 | −2.99 | 136 | −73.73 |
| Capex | 3.01 | 7.03 | 5.02 | 20.07 | 23.09 | 13.05 | 17.07 | 11.04 | 7.02 | 12.05 | 145 | 31.11 |
| Free cash flow | 27.07 | 40.12 | 51.16 | 31.07 | 10.02 | 36.08 | 63.17 | 37.13 | 86.27 | 121 | −82.28 | 96.35 |
| CFO / OP % | 107.0% | 107.0% | 104.0% | 96.0% | 80.0% | 118.0% | 136.0% | 60.0% | 103.0% | 120.0% | 71.0% | 97.0% |
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 52 | 58 | 52 | 69 | 74 | 56 | 66 | 60 | 57 | 54 | 61 | 59 |
| Inventory days | 83 | 84 | 99 | 74 | 73 | 76 | 88 | 94 | 72 | 67 | 77 | 70 |
| Days payable | 56 | 65 | 74 | 74 | 72 | 57 | 104 | 87 | 68 | 82 | 77 | 62 |
| Cash conversion cycle | 83 | 81 | 81 | 72 | 79 | 78 | 55 | 71 | 65 | 42 | 65 | 71 |
| Working capital days | 59 | 56 | 56 | 63 | 70 | 60 | 47 | 58 | 49 | 34 | 57 | 57 |
| ROCE % | 35.0% | 39.9% | 40.9% | 32.9% | 22.9% | 17.9% | 18.9% | 16.9% | 21.9% | 27.9% | 22.9% | 20.9% |
For the Jun 2026 quarter, Elantas Beck India reported sales of ₹283 Cr, up 34.7% year on year and net profit of ₹71.02 Cr, up 82.0% year on year. The operating margin was 29.0%.
Elantas Beck India's sales for the year to Dec 2025 were ₹850 Cr; over the last twelve months they were ₹938 Cr.
Net profit for the year to Dec 2025 was ₹148 Cr, and ₹177 Cr over the last twelve months. Earnings per share over the same trailing period were ₹223.56.
Elantas Beck India reported borrowings of ₹0 Cr at Dec 2025, against cash and equivalents of ₹69.07 Cr.
Cash from operations was ₹127 Cr in the year to Dec 2025; after capital spending, free cash flow was ₹96.35 Cr.